期刊文献+

膀胱非霍奇金淋巴瘤1例 被引量:1

下载PDF
导出
摘要 患者女,59岁,主因下腹部憋胀疼痛不适感半月余2012年8月入院。主要症状有轻度尿频,未见明显肉眼血尿、无排尿困难、排尿中断,无发热等症状。查体无异常。入院肿瘤全项化验显示,
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2013年第3期182-182,共1页 Chinese Journal of Clinical Oncology
  • 相关文献

参考文献4

二级参考文献24

  • 1孙燕 周际昌.临床肿瘤内科手册[M].北京:人民卫生出版社,2003.586-591.
  • 2Korl AD,le Cessie S,Snijder S,et al.Primary extranodal non-Hodgkins lymphoma(NHL):the impact of alternative definitons tested in the Comprehensive Cancer Centre West population-based NHL registry[ J ].Ann Oncol,2003,14 (1):131-139.
  • 3MORSCHHAUSER F, LEONARD J P, FAYAD L, etal. Humanized anti-CD20 antibody?veltuzumab, in refrac-tory/ recurrent non-Hodgkin,s lymphoma: phase T/II re-sults[J]. J Clin Oncol,2009,27 :3346-3353.
  • 4MICAILEF I N,MAURER M J, WISEMAN G,et al_Epratuzumab with rituximab, cyclophosphamide, doxoru-bicin, vincristine, and prednisone chemotherapy ( ER-CH()P)in patients with previously untreated diffuse largeB-cell lymphoma[J]. Blood?2011,118:4053 —4061.
  • 5ADVANI R, FOREROTORRES A,FURMAN R R,etal. Phase I study of the humanized anti-CD40 monoclonalantibody dacetuzumab in refractory or recurrent non-Hodgkin^ lymphoma[J]. J Clin Oncol,2009,27 : 4371 —4377.
  • 6LOZANSKI G,HEEREMA N’FLINN I,et al. Alemtu-zumab is an effective therapy for chronic lymphocyticleukemia with p53 mutations and deletions [J]. Blood,2004,103:3278—3281.
  • 7STOPECK A T, UNGER J M,RIMSZA L M,et al. Aphase n trial of single agent bevacizumab in patients withrelapsed, aggressive non-Hodgkin lymphoma: Southwestoncology group study S0108[J]. Leuk Lymphoma,2009,50:728 — 735.
  • 8HURWITZ H,FEHRENBACHER L, NOVOTNY W,et al. Bevaciz mab plus irinotecan, fluorouracil, and leuco-vorin for metastatic colorectal cancer[J]. N Engl J Med,2004,350:2335 — 2342.
  • 9GERBER H P,FERRARA N. Pharmacology and phar-macodynamics of bevacizumab as monotherapy or in com-bination with cytotoxic therapy in preclinical studies[J].Cancer Res, 2005,65 : 671 — 680.
  • 10GANJCO K N,AN C S,ROBERTSON MJ,et al. Ritux-imab,bevacizumab and CHOP ( RA-CHOP) in untreateddiffuse large B-cell lymphoma: safety, biomarker, andpharmacokinetic analysis[J]. Leuk Lymphoma, 2006?47 :998-1005.

共引文献5

同被引文献7

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部